Try our Advanced Search for more refined results
March 11, 2005
In re Forest Laboratories, Inc. Securities Litigation
Case Number:
1:05-cv-02827
Court:
Nature of Suit:
Multi Party Litigation:
Class Action
Judge:
Firms
- Brodsky Smith
- Cuneo Gilbert
- Debevoise & Plimpton
- Keker Van Nest & Peters
- Milberg Coleman
- Motley Rice
- Robbins Geller
Companies
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
February 02, 2009
Coughlin Stoia Attys Seek $18M In Celexa Deal Fees
Lead counsel for the plaintiffs in a securities class action alleging that Forest Laboratories Inc. provided misleading information about the safety of its blockbuster antidepressants Celexa and Lexapro have asked for more than $18 million in fees and expenses.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login